|
End-of-day quote
Shenzhen S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 9.560 CNY | +1.92% |
|
-2.85% | +20.40% |
| Market Cap | 5.56B 829M 739M 689M 627M 1.18B 79.88B 1.19B 8.32B 3.24B 40.79B 3.11B 3.05B 131B | P/E 2024 |
207x | P/E 2025 | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 5.39B 804M 717M 668M 608M 1.15B 77.46B 1.15B 8.07B 3.14B 39.55B 3.02B 2.95B 127B | EV / Sales 2024 |
3.29x | EV / Sales 2025 | 3.57x |
| Free-Float |
56.4% | Yield 2024 |
0.81% | Yield 2025 | - |
| 1 day | +1.92% | ||
| 1 week | -2.85% | ||
| 1 month | +12.87% | ||
| 3 months | +15.18% | ||
| 6 months | -4.59% | ||
| Current year | +20.40% |
| 1 week | 9.34 |  | 9.85 |
| 1 month | 7.82 | | 10.43 |
| Current year | 7.08 | | 11.38 |
| 1 year | 7.08 | | 11.38 |
| 3 years | 3.58 | | 11.98 |
| 5 years | 3.58 | | 11.98 |
| 10 years | 3.58 | | 14.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xu Wang
CEO | Chief Executive Officer | 42 | 11/12/2017 |
Ni Zeng
DFI | Director of Finance/CFO | 34 | 01/08/2019 |
Sen Li
COO | Chief Operating Officer | 45 | 25/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Xu Wang
CHM | Chairman | 42 | 01/08/2019 |
Ying Yang
CHM | Chairman | 48 | 21/03/2019 |
Ze Hui Shao
BRD | Director/Board Member | 46 | 21/03/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.92% | -2.85% | +12.21% | +38.35% | 829M | |
| +0.02% | -3.41% | +36.11% | +115.09% | 1,019B | |
| -1.21% | -6.74% | +34.08% | +62.64% | 617B | |
| +1.12% | +0.54% | +13.62% | +79.94% | 464B | |
| -3.30% | -6.21% | +56.45% | +36.58% | 356B | |
| +0.93% | -3.16% | +21.65% | +43.02% | 333B | |
| +0.12% | -2.77% | +10.70% | +32.97% | 267B | |
| -0.89% | -6.28% | -7.00% | +8.01% | 244B | |
| -0.01% | -2.81% | +35.28% | +51.82% | 218B | |
| -0.08% | -4.17% | +28.34% | +93.51% | 179B | |
| Average | -0.10% | -3.90% | +24.14% | +56.19% | 369.8B | |
| Weighted average by Cap. | -0.15% | -3.54% | +28.50% | +70.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 984M 147M 131M 122M 111M 209M 14.13B 210M 1.47B 573M 7.21B 551M 539M 23.17B | 1.21B 180M 160M 149M 136M 256M 17.31B 258M 1.8B 702M 8.84B 675M 660M 28.39B |
| Net income | 13.65M 2.04M 1.81M 1.69M 1.54M 2.9M 196M 2.92M 20.43M 7.95M 100M 7.64M 7.48M 322M | 92.73M 13.83M 12.33M 11.49M 10.46M 19.72M 1.33B 19.84M 139M 53.99M 680M 51.93M 50.8M 2.18B |
| Net Debt | 189M 28.2M 25.14M 23.43M 21.33M 40.2M 2.72B 40.45M 283M 110M 1.39B 106M 104M 4.45B | -169M -25.18M -22.44M -20.92M -19.04M -35.89M -2.42B -36.11M -253M -98.27M -1.24B -94.53M -92.48M -3.98B |
Employees
1,188
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | CNY 9.560 | +1.92% | 33,479,841 |
| 29/09/26 | CNY 9.380 | -1.16% | 31,612,779 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300016 Stock
Select your edition
All financial news and data tailored to specific country editions
